|
1 Indications And Usage Risperdal ® Is An Atypical Antipsychotic Indicated For: Treatment Of Schizophrenia ( 1.1 ) As Monotherapy Or Adjunctive Therapy With Lithium Or Valproate, For The Treatment Of Acute Manic Or Mixed Episodes Associated With Bipolar I Disorder ( 1.2 ) Treatment Of Irritability Associated With Autistic Disorder ( 1.3 ) 1.1 Schizophrenia Risperdal ® (risperidone) Is Indicated For The Treatment Of Schizophrenia. Efficacy Was Established In 4 Short-Term Trials In Adults, 2 Short-Term Trials In Adolescents (ages 13 To 17 Years), And One Long-Term Maintenance Trial In Adults [see Clinical Studies (14.1) ] . 1.2 Bipolar Mania Monotherapy Risperdal ® Is Indicated For The Treatment Of Acute Manic Or Mixed Episodes Associated With Bipolar I Disorder. Efficacy Was Established In 2 Short-Term Trials In Adults And One Short-Term Trial In Children And Adolescents (ages 10 To 17 Years) [see Clinical Studies (14.2) ] . Adjunctive Therapy Risperdal ® Adjunctive Therapy With Lithium Or Valproate Is Indicated For The Treatment Of Acute Manic Or Mixed Episodes Associated With Bipolar I Disorder. Efficacy Was Established In One Short-Term Trial In Adults [see Clinical Studies (14.3) ] . 1.3 Irritability Associated With Autistic Disorder Risperdal ® Is Indicated For The Treatment Of Irritability Associated With Autistic Disorder, Including Symptoms Of Aggression Towards Others, Deliberate Self-Injuriousness, Temper Tantrums, And Quickly Changing Moods. Efficacy Was Established In 3 Short-Term Trials In Children And Adolescents (ages 5 To 17 Years) [see Clinical Studies (14.4) ] .
|